You’re within the Norms (@UrWithintheNorm) header
You’re within the Norms (@UrWithintheNorm) profile picture

FAMU Grad #Rattler, UofF Grad #Gator, UofM Grad #GoBlue. Rx & D.D.S. #ΚΑΨ

Joined December 2019
Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)Photo by You’re within the Norms (@UrWithintheNorm)
You’re within the Norms retweeted
🚩 MASS TORT CRISIS Friends don't let friends get seduced by psychological warfare ~ by Suboxone PUSHER Pied Piper Klodney & his traveling Mass Tort ADDICTS in their settlement SEEKING circus & his PROP SLOP parade EXPLOITING crying Moms ~ DON'T surrender ur GOD given RIGHTS!
Full agonist opioids save lives! THEY ARE OUR CURE STOP DEMONIZING OPIOIDS YOU ARE KILLING US Advocate for full access to the medication & dosage that ensures relief, function, & ensures a quality of life that's acceptable to US! #PainCareCrisis #MedTwitter #ChronicPain #MAHA
1
2
2
42
You’re within the Norms retweeted
FRAUD EXPOSED in CDC guidelines DEA intrusion in medical treatment & the laundering of opioid settlement money, the addiction & recovery industry, Andrew Klodney, PROP & FedUp *recently it was exposed cops are using opioid settlement money to buy Flock ALPR surveillance cameras
FRAUD EXPOSED in CDC guidelines DEA intrusion in medical treatment & the laundering of opioid settlement money, the addiction & recovery industry, Andrew Klodney, PROP & FedUp *recently it was exposed cops are using opioid settlement money to buy Flock ALPR surveillance cameras
1
3
2
64
You’re within the Norms retweeted
What if overeating isn’t the cause of obesity—but a consequence? Join @JonEntine, @camjenglish, and @DrLizaMD, with author and science journalist @garytaubes, who challenges the conventional “calories in, calories out” explanation for obesity. nitter.gq/i/spaces/1NgQlRAYbQjzE…

1
5
3
12
3,198
You’re within the Norms retweeted
Replying to @UrWithintheNorm
Replying to @USAO_MIE
U.S. vs. Bothra et al. Only in Detroit… Can federal prosecutor #BrandyMcMillion indict fully licensed and credentialed physicians for doing a job they were trained for. Not understand the specific elements of each of the charges. Not follow the government’s very own rules, regulations and requirements before bringing criminal charges against a medical professionals. Rely on a “whistleblower” physician who has never seen a single patient in an unsupervised setting before. Pay a crack cocaine addicted confidential informant $17,000 cash to wear a wire to try and set the doctors up to commit crimes. Have their own “experts” from Blue Cross of Michigan, Medicare and Medicaid all testify in court that their investigation “reviews” Demonstrated no evidence of criminal behaviors. Secure a prosecution medical expert witness who made 14 review errors on just 6 files justifying the charges and then was caught lying about it under oath. Prosecutor then loses the biggest healthcare fraud trial in U.S. history and gets shielded from her incompetence while actually being promoted via the presidential autopen to Michigan federal judge. And is then caught scrubbing and sanitizing her own personal Wikipedia online profile of all mention of her lead role in the humiliating Dr. Raj Bothra federal trial loss.
1
1
31
You’re within the Norms retweeted
Excellent post 👇🏽
The FDA Commissioner role is open again. Dr. Heidi Overton’s nomination was pulled the night before her Senate committee vote. Whatever the internal reasons, this creates a rare opening to get the leadership right for American patients and for the innovation that actually reaches them. Here’s what the next Commissioner needs to be. Not a wish list. A baseline: You cannot regulate what you have never lived. The person in this seat should have spent real time on the other side of the table—building a product in biotech, pharma, or devices—and felt the weight of regulatory decisions as the recipient (sometimes the victim). That experience is not optional. Career government officials and pure academics can be talented, but they have never had a program delayed, a trial redesigned, or a company nearly killed by a decision whose full consequences they never had to carry. The ethics rules make it extremely difficult for anyone with industry experience to take this job because of the divestiture requirements. The result is that the role often defaults to people who have never created anything. That may be administratively easier. There is a price. This person must be a licensed physician—ideally a physician-scientist—who has done both basic and clinical research and who has actually taken care of patients. An active license is ideal. They need to understand, firsthand, what patients face, including patients with rare diseases. For many of those conditions it is mathematically nearly impossible to hit a p-value of 0.05, the arbitrary threshold we treat as the definition of statistical significance. That reality has to be lived, not just read about. The role is sacred. It involves life-and-death decisions for millions of people. It is therefore not a platform for partisan ideology. Americans are sick of extreme partisanship. The next Commissioner should be objective, serve all Americans, and recognize that this job is not subject to partisan manipulation. They should be blindly loyal to exactly one large and powerful special-interest group: THE AMERICAN PEOPLE. Full stop. They should be well-spoken and confident in public settings, yet humble enough to welcome feedback and constructive criticism. They should not arrive with their mind made up on specific drugs or classes of drugs before they have seen the data. The FDA’s job is not to decide whether a particular patient should receive a particular drug. That decision belongs to the physician and the patient once the science is sound and the information is clear. Every regulatory choice carries 2 risks: the risk of approving something that later proves harmful, and the risk of not approving something that could have helped. Both are real. For patients with serious or rare conditions and few options, the second risk is often larger. This is also a national-security position. It requires a counterintelligence background check (don’t ask how I know 😉) for a reason: the wrong decision or the wrong public (or private) statement can do real harm. The person who holds it should treat that responsibility with the seriousness it deserves—focused on the work, not on being a constant public figure, & never hinting at confidential information. They may hold strong personal, cultural, or religious beliefs. Those beliefs stay at the door. The job is to follow the law and to do what is medically, scientifically, and ethically right for American patients. Bring back open, FAIR advisory committee meetings so the public can see how decisions are made. Keep asking not only “Is it safe enough to approve?” but “What happens if we do not?” Protect the public from products that offer real risk with no benefit, while trusting informed patients and physicians when credible evidence exists that a treatment can help This is a moment to choose leadership that is responsive to the needs of all Americans—objective, compassionate, and thoughtful. American patients & American innovation are counting on it.
1
159